Artificial Intelligence in Colonoscopy Surveillance for Lynch Syndrome: Emerging Evidence, Lessons Learned From Average-Risk Populations, and Future Directions.

Key Takeaways for GI Nurses

• Artificial intelligence technology is being evaluated for enhanced polyp detection during colonoscopy surveillance in Lynch syndrome patients, who require more intensive screening protocols than average-risk populations
• Lessons learned from AI implementation in routine colonoscopy procedures are informing best practices for high-risk hereditary cancer syndrome surveillance programs
• GI nurses should prepare for potential integration of AI-assisted colonoscopy systems that may change pre-procedure preparation, intra-procedure monitoring, and post-procedure documentation workflows
• Understanding AI capabilities and limitations will become essential for patient education and informed consent discussions, particularly for Lynch syndrome patients who face increased cancer risks

Clinical Relevance

This research has significant implications for endoscopy nursing practice, particularly in units that serve high-risk patient populations. Lynch syndrome patients require lifelong surveillance colonoscopies beginning at younger ages and performed more frequently than standard screening protocols. The integration of AI technology into these surveillance procedures could enhance our ability to detect adenomas and early cancers in this vulnerable population. For GI nurses, this means staying current with evolving technology while maintaining expertise in the unique care requirements of hereditary cancer syndrome patients, including their increased anxiety levels, complex family histories, and need for genetic counseling coordination.

From an operational standpoint, AI-assisted colonoscopy may require modifications to existing unit protocols and staff training programs. Endoscopy nurses will need to understand how AI systems function during procedures, recognize when technology alerts require immediate attention, and troubleshoot potential technical issues that could impact procedure quality. Additionally, the integration of AI findings into procedure reports and follow-up recommendations may necessitate updates to documentation standards and communication protocols with referring physicians and genetic counselors.

The professional development implications are equally important, as GI nurses must balance technological advancement with evidence-based patient care principles. Understanding the research foundation supporting AI use in average-risk populations, while recognizing the distinct challenges of Lynch syndrome surveillance, will be crucial for maintaining clinical competency and providing optimal patient advocacy throughout the screening process.

Bottom Line

As artificial intelligence technology advances from research settings into clinical colonoscopy practice, GI nurses must prepare for its potential integration into Lynch syndrome surveillance programs by understanding both the technological capabilities and the unique clinical needs of high-risk hereditary cancer patients. This preparation includes staying informed about emerging evidence, adapting unit protocols for AI-enhanced procedures, and maintaining the specialized knowledge required to care for patients with complex genetic cancer syndromes who depend on regular endoscopic surveillance for early detection and prevention.